Concert Series Raises Millions for Cancer Research
The successful San Diego charity model offers a template for how large-scale events drive significant capital to non-profits.
Updated on Oct. 25, 2026 in Philanthropy
Live Poll
Should private fundraising initiatives play a larger role in supporting national scientific research?
The Concert for Cures series raised $8.25 million for cancer research during a May 15, 2026, performance by Pink at Petco Park in San Diego. The event series has now generated more than $28 million in total funding since its inception in 2022.
Why it matters
These contributions provide essential backing for cancer research efforts during a period of uncertainty regarding national research funding. Such private philanthropic models offer operators an example of how large-scale community events can drive significant capital toward non-profit initiatives.
Curebound has awarded $51.5 million in research grants supporting 170 studies, a figure that has helped projects secure $161 million in follow-on funding. The organization has successfully funded 28 clinical trials since the Concert for Cures series began in 2022.
The players
Curebound
A philanthropic organization that funds cancer research studies and clinical trials through large-scale community events.
Pink
An internationally recognized musical artist who performed at the May 2026 charity event.
The details
The initiative leverages major international musical talent to draw crowds, with 25,000 people attending the Pink concert alone and 60,000 total attendees across the four-event series. These funds support studies focused on the prevention, detection, and treatment of 23 different types of cancer. By utilizing high-profile San Diego venues like Petco Park and the Rady Shell at Jacobs Park, the series creates a scalable fundraising mechanism that connects mass-market entertainment with philanthropic objectives.
Timeline
2022: Concert for Cures series was initiated.
May 15, 2026: Pink performed at Petco Park in San Diego.
Market Landscape
The fundraising success follows the established model of the Curebound cancer research grant program, which leverages private donations to catalyze larger research investments. This event marks a continued reliance on high-profile entertainment partnerships to sustain local non-profit research pipelines.
Operators should observe how the event coordinates with major venues to maximize reach and capital efficiency for regional non-profits. The ability to attract $161 million in follow-on funding highlights the potential of private philanthropy to act as seed capital for larger research projects.
The takeaway
This event demonstrates the efficacy of entertainment-driven philanthropy in securing significant private research capital. Operators looking to align with similar community impact goals should monitor Curebound's ongoing clinical trial success rates as a metric for evaluating future philanthropic partnerships.
Further reading
For more on local community impact efforts, visit the San Diego Philanthropy section.
Source note: This article includes information reported by The Times of India.
Live Poll
Should private fundraising initiatives play a larger role in supporting national scientific research?
